Associated Papers
Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.
Jiménez-Ubieto A et al.
Frontiers in Immunology, 2023
37342332 (PubMed )
Supplement: Table_2.xlsx › Sheet1
Recurrent Mutations in the MTOR Regulator RRAGC in Follicular Lymphoma.
Ying ZX et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2016
Select a paper to view details